Tagma Pharma (Uk) Ltd - Limited company - abbreviated - 11.0.0

Tagma Pharma (Uk) Ltd - Limited company - abbreviated - 11.0.0


05797558 1.5.13 30.4.14 30.4.14 Company accounts Private Limited Company FY true false true false true false false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure057975582013-04-30057975582014-04-30057975582013-05-012014-04-30057975582012-04-30057975582012-05-012013-04-30057975582013-04-3005797558ns12:England2013-05-012014-04-3005797558ns14:PoundSterling2013-05-012014-04-3005797558ns7:Director12013-05-012014-04-3005797558ns7:OrdinaryShareClass12013-05-012014-04-3005797558ns7:CompanySecretary2013-05-012014-04-3005797558ns7:RegisteredOffice2013-05-012014-04-3005797558ns7:OrdinaryShareClass12014-04-3005797558ns7:OrdinaryShareClass12013-04-30
REGISTERED NUMBER: 05797558 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 30 April 2014

for

Tagma Pharma (Uk) Ltd

Tagma Pharma (Uk) Ltd (Registered number: 05797558)






Contents of the Abbreviated Accounts
for the Year Ended 30 April 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

Tagma Pharma (Uk) Ltd

Company Information
for the Year Ended 30 April 2014







DIRECTOR: N H Shaikh





SECRETARY: M N Shami





REGISTERED OFFICE: Morgan Reach Chartered Certified Account
C I B A Building
146 Hagley Road
Birmingham
B16 9NX





REGISTERED NUMBER: 05797558 (England and Wales)

Tagma Pharma (Uk) Ltd (Registered number: 05797558)

Abbreviated Balance Sheet
30 April 2014

30.4.14 30.4.13
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 79 106

CURRENT ASSETS
Debtors - 1,619
Cash at bank 103 230
103 1,849
CREDITORS
Amounts falling due within one year (1 ) 483
NET CURRENT ASSETS 104 1,366
TOTAL ASSETS LESS CURRENT
LIABILITIES

183

1,472

CREDITORS
Amounts falling due after more than one
year

-

32
NET ASSETS 183 1,440

CAPITAL AND RESERVES
Called up share capital 3 1 1
Profit and loss account 182 1,439
SHAREHOLDERS' FUNDS 183 1,440

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2014 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 22 September 2014 and were signed by:



N H Shaikh - Director


Tagma Pharma (Uk) Ltd (Registered number: 05797558)

Notes to the Abbreviated Accounts
for the Year Ended 30 April 2014

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.


Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 May 2013
and 30 April 2014 800
DEPRECIATION
At 1 May 2013 694
Charge for year 27
At 30 April 2014 721
NET BOOK VALUE
At 30 April 2014 79
At 30 April 2013 106

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.4.14 30.4.13
value: £    £   
1 Ordinary £1 1 1